Kwivik therapeutics, Inc.

Frisco, TX 75036, US
Medical Devices & Equipment

Kwivik is a medtech leader that develops products that allow family, co-workers or bystanders to safely and easily aid the rescue of anyone in a medical or respiratory emergency with little to no training.

The Oxygen Problem

What is the single most important thing you need in any medical emergency? As any paramedic will tell you, it’s emergency oxygen! If the mass public didn’t know this before, COVID-19 has jammed this into our collective global consciousness.

However, oxygen today comes in bulky, flammable and possibly explosive compressed tanks that require serious training to operate. This kind of technology is unfortunately unavailable to the public for use in a medical emergency.

As of now, there is no safe and easy way to deploy emergency oxygen where and when it is needed most – right at the time and place the emergency happens – at home, school, work, on trains, planes, golf courses and virtually anywhere in the community.

Now that we know how important it is to have oxygen on-hand in the event of a medical emergency, it’s time for the technology to catch up.

Enter: Kwivik Therapeutics.

Expanding Access

Kwivik has perfected a way to create medical oxygen from two dry, inert powders. Because it can be stored safely and thus used anywhere, our technology is revolutionizing public medical safety by granting broader access to this life-saving emergency aid.

The powders used in our proprietary processes remain inert while they are hermetically separated from each other. At a touch of button, these powders combine to form medical grade oxygen instantly. This innovative "oxygen from powder" technology eliminates the need for pressurized oxygen storage.

With this technology, oxygen is generated on demand. Since there are no compressed tanks, there are no regulators, dials, valves, or training required to use. Our technology eliminates the dangerous aspects of traditional oxygen to allow more people to save more lives.

Kwivik’s products allow anyone, with little to no training, to save lives, improve medical outcomes and help people in any medical emergency, all before paramedics arrive on the scene.

General Information


Social Links

Company Industry

Select Industry:

Company Description

0 / 250
0 / 2000


Prior Year Revenue Current Year Revenue Next Year Revenue
Company Age Employees Sub-Industry
4 years, 10 months 15 Therapeutic

Company Financials

Viewable by EquityNet investors only

Company Age & Size


Products / Services

0 / 1000
O2Fast / InRespi / O2Ventilate / Valinin

O2fast | A lightweight, portable emergency oxygen device that works with a turn of a knob. It will provide 6 liters per minute of medical oxygen for up to 20 minutes, long enough until the paramedics arrive on the scene. O2Fast is the perfect companion product to the AED.

InRespi | InRespi brings the standard of care for an asthma attack to the places where they happen the most: at home, school or the workplace. InRespi is simple and safe for asthma patients to use whenever they need it in their daily lives.

O2 Ventilate | Most of us remember the worldwide shortage of ventilators at the start of COVID-19. O2 Ventilate is a simple, manually operated ventilator that is portable, affordable, and safe, and requires minimal training to use.

Valinin | Cluster headache and Migraine sufferers can now get relief with this high-flow oxygen taken at or before the onset of a migraine. Oxygen as a vasodilator will ameliorate the episode if treated early, especially at high flow rates.


0 / 1000
Chief Executive Officer
Julian Ross

Julian RossJulian Ross, GROUP CHAIRMAN AND CEO | Mr. Ross has led and closed all financing and acquisitions by Kwivik Therapeutics Inc. He has invested over $7 million of over $50 million total in the company. Mr. Ross brings 30+ years of experience in biotech/medtech, high tech, R&D, manufacturing, sales and corporate finance.

Director Finance
Robert Fox

Robert FoxRobert Fox, CHAIRMAN, AUDIT COMMITTEE | Robert brings 38+ years of experience in accelerating growth, creative problem solving, operations management, accounting, audit and finance. He spent 32 years at a Fortune 200 company, mastering roles including Chief Accounting Officer, Division CFO Manufacturing and Senior Manager Global Development.

Director Strategic Affairs
Rohan Hoare

Rohan HoareRohan Hoare, CHAIRMAN, NOMINATING COMMITTEE | Dr. Hoare is a proven leader with demonstrated success in the medical device industry. He is skilled in Market Development, Commercialization, Strategy, Product Development, Clinical Research, Quality and Manufacturing.

Vice President Physician/Medical Officer
Luis M. Salmun

Luis M. SalmunLuis M. Salmun, CHIEF MEDICAL OFFICER | Dr. Salmun has over three decades experience in medicine and medical affairs, research, clinical, healthcare insurance and regulatory registration and approvals; with specialties that include Immunology and Allergy, Asthma, COPD, Cardiovascular Disease, Diabetes and Pediatrics.

Senior Vice President Financial Officer
Jeff Robertson

Jeff RobertsonJeff Robertson, INTERIM CHIEF FINANCIAL OFFICER? | Jeff is a proven senior financial professional with demonstrated capabilities in preparing companies for strategic transactions and improving under-performing functions.

Vice President Information Technology
Ronald Redmer

Ronald RedmerRonald Redmer, CHIEF INFORMATION OFFICER | Ronald is a strategic and results-driven business and technology executive with a proven track record of over three decades of leadership in global IT operations, technology startups, major organizational transformations, acquisitions and divestitures and large-scale solution delivery.

Vice President Research & Development
John C. Tepper

John C. TepperJohn C. Tepper, VP, PRODUCT DEVELOPMENT & REGULATORY | John as over four decades experience in product development, operations, regulatory affairs and quality control.

Vice President Sales & Marketing
Ed Huntsberry

Ed HuntsberryEd Huntsberry, VP, HUMAN RESOURCES AND CUSTOMER RELATIONS | Ed has more than a decade experience in medical devices, emergency medical technologies and oxygen, and over four decades senior management experience in sales, retail, operations and customer service.

Investors / Lenders

Add investors/lenders that are already on EquityNet by typing their name and then selecting them from the drop-down.
Add investors/lenders that are not yet on EquityNet by typing their name, selecting "Add a New Investor", and filling in additional information.

Debt Provider
Silicon Valley Bank

For more than 35 years, SVB has helped innovators and their investors move bold ideas forward fast. Today, SVB provides a range of banking services to companies of all sizes in innovation centers around the world.

Venture Capital Fund
Vencore Capital, LLC

Vencore Capital was founded by entrepreneurs who have served emerging-growth companies with venture debt financing for the past 20 years. Vencore distinguishes itself from other lenders by our commitment to provide capital earlier in a company's lifecycle — prior to traditional venture-capital financing — and through our willingness to do smaller deals with more flexible structures and pricing. Our approach is to match the size, structure and pricing to our clients' risk profiles. Our deals typically range from $50K to $2M.

Individual Investor
Jeremy M Jones

Founder, Chairman & CEO, Apria Healthcare Group
Chairman of the Board of Directors, ASGN Inc (NYSE: ASGN)

Individual Investor
Steven Hill

Global Head of Innovation, KPMG

Steve is the Global Head of Innovation at KPMG LLP, an audit, tax and advisory firm. In this role, he meshes the art and science of innovation to drive market relevance and sustainable growth. His connections to market trends and growth strategies have made him a thought leader and change agent on innovation and business transformation.

Steve previously served in several KPMG leadership positions, including U.S. and Global Leader of Innovation for KPMG’s Advisory business, Global Leader for IT Strategy and CIO advisory services, and other major industry and geographic leadership roles.

Prior to joining KPMG, Steve was Managing Director of Strategic Planning for SHL Systemhouse, where he was a contributing architect in the creation of Transformational Outsourcing. Steve also served as consultant at McKinsey & Co. and is a graduate of the United States Merchant Marine Academy. He holds an MBA from Harvard University.

Individual Investor
Vicki Jones

Former Vice President, Operations for AT&T Worldwide

Non-Profit Funding Source
Frisco Economic Development Corporation

When it comes to corporate relocation and business expansion opportunities, Frisco means business. Strategically located 25 miles north of Dallas in the hotbed of the North Platinum Corridor, Frisco is one of the most desirable locations in the United States to live, work, play, educate, and innovate.

In this dynamic and thriving community, the Frisco Economic Development Corporation’s mission is the creation of jobs, increasing economic opportunities, and improving quality of life for all Frisco residents and their families.



Funding Goal$20,000,000

Funding Raised So Far$0

Funding Commitments$0

Funding Remaining$20,000,000

Funding TypeEquity

Pre-Money Valuation

Investor Ownership

Interest / Dividend

Previous Funding

General Funding


Showing your General Funding information publicly may constitute general solicitation. General solicitation is a new commonly-used way for companies to raise funding. To learn about general solicitation, consult your legal counsel. If you uncheck this box, your General Funding information will be viewable to only EquityNet investors.

Private Funding

Viewable by EquityNet investors only


Kwivik therapeutics, Inc. Image 1
Kwivik therapeutics, Inc. Image 2
Kwivik therapeutics, Inc. Image 3
Kwivik therapeutics, Inc. Image 4
Kwivik therapeutics, Inc. Image 5
Kwivik therapeutics, Inc. Image 6



Complete a Business Plan in EquityNet

Your EquityNet business plan is only viewable to capital providers and business supporters that you choose to share with in the “Crowdfund” or “Messages” tab. Investors prefer an EquityNet business plan. Entering a plan is highly educational and improves your appeal to investors.

Upload Documents

Document file names will be viewable by EquityNet investors and business supporters only. Actual documents are only viewable to capital providers and business supporters that you choose to share with in the “Crowdfund” or “Messages” tab.

Share Your Public Profile Page

Users who follow all these tips increase their fundraising odds substantially.

  • Email your public page to all your LinkedIn contacts.
    • Post your page to your LinkedIn profile page.
  • Email your public page to all your Facebook contacts.
    • Post your page to your Facebook profile page.
  • Email your public page to all your Twitter contacts.
    • Post your page to your Twitter profile page.
  • Put your public page up on your website.
    • Don't have a website yet? Use this page as your site!
  • Share your page link anywhere there's a listing for your company.
    • Press Releases, Crunchbase, Wikipedia, Blogs, etc...
  • Email your public page to all your email contacts.
    • Use Outlook, Gmail, Yahoo Mail, Hotmail, etc...

Your Public Profile Page:

Would you like to share your public profile page with your email contacts?